Neurofilaments and neurological disease.

Neurofilaments are one of the major components of the neuronal cytoskeleton and are responsible for maintaining the calibre of axons. They are modified by post-translational changes that are regulated in complex fashions including by the interaction with neighbouring glial cells. Neurofilament accumulations are seen in several neurological diseases and neurofilament mutations have now been associated with Charcot-Marie-Tooth disease, Parkinson's disease and amyotrophic lateral sclerosis. In this review, we discuss the structure, normal function and molecular pathology of neurofilaments.

[1]  J. Julien,et al.  Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.

[2]  W. Blackstock,et al.  Identification of Phosphorylation Sites on Neurofilament Proteins by Nanoelectrospray Mass Spectrometry* , 1997, The Journal of Biological Chemistry.

[3]  D. Cleveland,et al.  A mutant neurofilament subunit causes massive, selective motor neuron death: Implications for the pathogenesis of human motor neuron disease , 1994, Neuron.

[4]  G. Halliday,et al.  Neurofilament-Immunoreactive Neurons in Alzheimer's Disease and Dementia with Lewy Bodies , 2002, Neurobiology of Disease.

[5]  P. Wong,et al.  The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation , 1993, The Journal of cell biology.

[6]  Lei Wang,et al.  Rapid movement of axonal neurofilaments interrupted by prolonged pauses , 2000, Nature Cell Biology.

[7]  J. Priestley,et al.  Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. , 1999, Diabetes.

[8]  J. H. Wang,et al.  Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. , 1992, The Journal of biological chemistry.

[9]  B. Helfand,et al.  Fast transport of neurofilament protein along microtubules in squid axoplasm. , 2000, Journal of cell science.

[10]  J. Trojanowski,et al.  Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation , 1997, The Journal of cell biology.

[11]  J. Kong,et al.  Overexpression of neurofilament subunit NF-L and NF-H extends survival of a mouse model for amyotrophic lateral sclerosis , 2000, Neuroscience Letters.

[12]  T B Shea,et al.  Phospho-dependent association of neurofilament proteins with kinesin in situ. , 2000, Cell motility and the cytoskeleton.

[13]  R. Nixon,et al.  Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber , 1994, The Journal of cell biology.

[14]  C. Shaw,et al.  Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons , 2000, The Journal of cell biology.

[15]  T. Sakaguchi,et al.  Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail , 1993, Neuroscience Letters.

[16]  G. Hart,et al.  Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. , 1993, The Journal of biological chemistry.

[17]  M. Oda,et al.  Cortical ballooned neurons in progressive supranuclear palsy , 1996, Neuroscience Letters.

[18]  J. Slade,et al.  Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS) , 1998, Neuroreport.

[19]  J. A. Cohlberg,et al.  Neurofilament Protein Heterotetramers as Assembly Intermediates (*) , 1995, The Journal of Biological Chemistry.

[20]  Y. Ono,et al.  PKN Associates and Phosphorylates the Head-Rod Domain of Neurofilament Protein (*) , 1996, The Journal of Biological Chemistry.

[21]  W. Blackstock,et al.  Identification of novel in vitro PKA phosphorylation sites on the low and middle molecular mass neurofilament subunits by mass spectrometry. , 1998, Biochemistry.

[22]  Z. S. Xu,et al.  Identification of six phosphorylation sites in the COOH-terminal tail region of the rat neurofilament protein M. , 1992, The Journal of biological chemistry.

[23]  H. Pant,et al.  Myelin‐associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases , 2002, Journal of neurochemistry.

[24]  M. Koenig,et al.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.

[25]  J. Trojanowski,et al.  Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits , 1995, The Journal of cell biology.

[26]  N. Hirokawa,et al.  Two distinct functions of the carboxyl-terminal tail domain of NF-M upon neurofilament assembly: cross-bridge formation and longitudinal elongation of filaments , 1995, The Journal of cell biology.

[27]  Y. Wada,et al.  Casein kinase II is responsible for phosphorylation of NF‐L at Ser‐473 , 1999, FEBS letters.

[28]  N. Calcutt,et al.  Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport , 2002, The Journal of cell biology.

[29]  John A. Martin,et al.  Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders , 1996, Acta Neuropathologica.

[30]  C. Shaw,et al.  Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. , 2000, Journal of cell science.

[31]  Steven H Y Hsieh,et al.  Regional modulation of neurofilament organization by myelination in normal axons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  H. Pant,et al.  cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  N. Hirokawa,et al.  The C-terminal tail domain of neurofilament protein-H (NF-H) forms the crossbridges and regulates neurofilament bundle formation. , 2000, Journal of cell science.

[34]  A. Grierson,et al.  Axonal transport of neurofilaments in normal and disease states , 2002, Cellular and Molecular Life Sciences CMLS.

[35]  G. Rouleau,et al.  Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis , 1996, Neurology.

[36]  P. Janmey,et al.  Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin. , 2000, Molecular biology of the cell.

[37]  H. Pant,et al.  Neurofilament protein synthesis and phosphorylation , 2000, Journal of neurocytology.

[38]  K. Fukunaga,et al.  Activation of Mitogen‐Activated Protein Kinase in Cultured Rat Hippocampal Neurons by Stimulation of Glutamate Receptors , 1995, Journal of neurochemistry.

[39]  Q. Zhu,et al.  Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Borchelt,et al.  Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease , 1996, Neurology.

[41]  Elaine Fuchs,et al.  Integrators of the Cytoskeleton that Stabilize Microtubules , 1999, Cell.

[42]  S. Brady,et al.  Local control of axonal properties by schwann cells: Neurofilaments and axonal transport in homologous and heterologous nerve grafts , 1991, Journal of neuroscience research.

[43]  L. WilliamsonT,et al.  神経フィラメントの欠如は,家族性筋萎縮性側索硬化症関連スーパオキジドジスムターゼ1変異に対する運動ニューロンの選択的易損性を低下させ,疾患を遅らせる , 1998 .

[44]  J. Julien,et al.  Late Onset Death of Motor Neurons in Mice Overexpressing Wild-Type Peripherin , 1999, The Journal of cell biology.

[45]  C. van Broeckhoven,et al.  Further evidence that neurofilament light chain gene mutations can cause Charcot‐Marie‐Tooth disease type 2E , 2001, Annals of neurology.

[46]  L. Tsai,et al.  Differential Cellular Phosphorylation of Neurofilament Heavy Side‐Arms by Glycogen Synthase Kinase‐3 and Cyclin‐Dependent Kinase‐5 , 1996, Journal of neurochemistry.

[47]  J. Julien,et al.  Disruption of the NF-H Gene Increases Axonal Microtubule Content and Velocity of Neurofilament Transport: Relief of Axonopathy Resulting from the Toxin β,β′-Iminodipropionitrile , 1998, The Journal of cell biology.

[48]  Veeranna,et al.  Regulation of axonal neurofilament phosphorylation. , 2000, Current topics in cellular regulation.

[49]  Jean-Pierre Julien,et al.  Neurofilaments in health and disease. , 1998, Progress in nucleic acid research and molecular biology.

[50]  B. Giasson,et al.  Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments* , 1996, The Journal of Biological Chemistry.

[51]  S. Meloche,et al.  Inhibition of Growth Factor-induced Protein Synthesis by a Selective MEK Inhibitor in Aortic Smooth Muscle Cells* , 1996, The Journal of Biological Chemistry.

[52]  G. Rouleau,et al.  Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. , 1993, Gene.

[53]  Sangmook Lee,et al.  The predominant form in which neurofilament subunits undergo axonal transport varies during axonal initiation, elongation, and maturation. , 2001, Cell motility and the cytoskeleton.

[54]  J. Julien,et al.  Multiple phosphorylation sites in mammalian neurofilament polypeptides. , 1982, The Journal of biological chemistry.

[55]  H. Pant,et al.  Integrins stimulate phosphorylation of neurofilament NF‐M subunit KSP repeats through activation of extracellular regulated‐kinases (Erk1/Erk2) in cultured motoneurons and transfected NIH 3T3 cells , 2001, Journal of neurochemistry.

[56]  N. Hirokawa,et al.  Phosphorylation of native and reassembled neurofilaments composed of NF-L, NF-M, and NF-H by the catalytic subunit of cAMP-dependent protein kinase. , 1994, Molecular biology of the cell.

[57]  P. Wong,et al.  Pathogenesis of two axonopathies does not require axonal neurofilaments , 1998, Nature.

[58]  A. Ohnishi,et al.  Greater number of microtubules per axon of unmyelinated fibers of mutant quails deficient in neurofilaments: possible compensation for the absence of neurofilaments , 1994, Acta Neuropathologica.

[59]  T. Shea,et al.  Neurofilaments Consist of Distinct Populations That Can Be Distinguished by C-Terminal Phosphorylation, Bundling, and Axonal Transport Rate in Growing Axonal Neurites , 2001, The Journal of Neuroscience.

[60]  J. Trojanowski,et al.  Attenuated Neurodegenerative Disease Phenotype in Tau Transgenic Mouse Lacking Neurofilaments , 2001, The Journal of Neuroscience.

[61]  R. Liem,et al.  Overexpression of α-Internexin Causes Abnormal Neurofilamentous Accumulations and Motor Coordination Deficits in Transgenic Mice , 1999, The Journal of Neuroscience.

[62]  Scott T. Brady,et al.  Neurofilaments Are Transported Rapidly But Intermittently in Axons: Implications for Slow Axonal Transport , 2000, The Journal of Neuroscience.

[63]  J. Julien,et al.  Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis , 1993, Cell.

[64]  A. Peterson,et al.  Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-β-galactosidase fusion protein , 1994, Neuron.

[65]  Veeranna,et al.  Mitogen-Activated Protein Kinases (Erk1,2) Phosphorylate Lys-Ser-Pro (KSP) Repeats in Neurofilament Proteins NF-H and NF-M , 1998, The Journal of Neuroscience.

[66]  R. Lazzarini,et al.  Age-associated and cell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized neurofilament subunit , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[67]  N. Hirokawa,et al.  Interaction of the tail domain of high molecular weight subunits of neurofilaments with the COOH-terminal region of tubulin and its regulation by tau protein kinase II. , 1993, The Journal of biological chemistry.

[68]  C. Miller,et al.  Phosphorylation of Neurofilament Heavy‐Chain Side‐Arm Fragments by Cyclin‐Dependent Kinase‐5 and Glycogen Synthase Kinase‐3α in Transfected Cells , 1997, Journal of neurochemistry.

[69]  A Al-Chalabi,et al.  Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. , 1999, Human molecular genetics.

[70]  D. Cleveland,et al.  Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons , 1999 .

[71]  K. Ishiguro,et al.  Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. , 1993, Journal of Biological Chemistry.

[72]  J. Julien,et al.  Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.

[73]  A. Hirano,et al.  Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.

[74]  Robert D. Goldman,et al.  Rapid Movements of Vimentin on Microtubule Tracks: Kinesin-dependent Assembly of Intermediate Filament Networks , 1998, The Journal of cell biology.

[75]  L. Bruijn,et al.  Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[76]  Q. Zhu,et al.  Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[77]  T. Crawford,et al.  Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport , 1996, The Journal of cell biology.

[78]  O. Evgrafov,et al.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.

[79]  J. Griffin,et al.  Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot‐Marie‐Tooth disease type 1 , 1994, Neurology.

[80]  J. Julien,et al.  Transgenic Mice in the Study of ALS: The Role of Neurofilaments , 1998, Brain pathology.

[81]  M. Polymeropoulos,et al.  A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration , 2002, Neuroscience Letters.

[82]  J. Gu,et al.  Integrin α1β1-Mediated Activation of Cyclin-Dependent Kinase 5 Activity Is Involved in Neurite Outgrowth and Human Neurofilament Protein H Lys-Ser-Pro Tail Domain Phosphorylation , 2000, The Journal of Neuroscience.

[83]  B. Khatra,et al.  Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3). , 1991, The Journal of biological chemistry.

[84]  P. Wong,et al.  Neurofilaments are obligate heteropolymers in vivo , 1993, The Journal of cell biology.

[85]  T. Kishimoto,et al.  Phosphorylation of neurofilament H subunit at the tail domain by CDC2 kinase dissociates the association to microtubules. , 1991, The Journal of biological chemistry.

[86]  Veeranna,et al.  Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. , 1999, European journal of biochemistry.

[87]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[88]  R. Goldman,et al.  Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[89]  O. Ohara,et al.  Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene , 1993, The Journal of cell biology.

[90]  R. Nixon,et al.  Serine‐23 Is a Major Protein Kinase A Phosphorylation Site on the Amino‐Terminal Head Domain of the Middle Molecular Mass Subunit of Neurofilament Proteins , 1999, Journal of neurochemistry.

[91]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[92]  T B Shea,et al.  Kinesin-mediated transport of neurofilament protein oligomers in growing axons. , 1999, Journal of cell science.

[93]  H. Gainer,et al.  Identification of Endogenously Phosphorylated KSP Sites in the High‐Molecular‐Weight Rat Neurofilament Protein , 1994, Journal of neurochemistry.

[94]  Z. S. Xu,et al.  Identification of serine 473 as a major phosphorylation site in the neurofilament polypeptide NF-L , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[95]  R. Schmidt,et al.  Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia , 1997, Brain Research.

[96]  R. Liem,et al.  Phosphorylation of the High Molecular Weight Neurofilament Protein (NF-H) by Cdk5 and p35* , 1996, The Journal of Biological Chemistry.

[97]  J. Trojanowski,et al.  Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  Ram K. Sihag,et al.  Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo , 2000, The Journal of cell biology.

[99]  E. O'ferrall,et al.  Inhibition of Aberrant and Constitutive Phosphorylation of the High‐Molecular‐Mass Neurofilament Subunit by CEP‐1347 (KT7515), an Inhibitor of the Stress‐Activated Protein Kinase Signaling Pathway , 2000, Journal of neurochemistry.